Skip to main content
Translational Pharmaceutics®

Quotient Sciences speaks with Outsourcing Pharma on what's ahead for CPhI

This article from Outsourcing Pharma describes how our team at Quotient Sciences is looking forward to reconnecting with customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US at CPhI North America.

Topics discussed include how we plan to stay ahead of industry trends and developments, recent partnerships and collaborations, challenges we are facing and how these are being addressed, future expansion plans, and insight into what sets us apart from industry competitors.

Read the full article here on the Outsourcing Pharma website.

Latest news from Quotient Sciences

More News
Articles & Publications, John McDermott, Dr. Andrew Lewis, Artificial Intelligence How AI Is Transforming Formulation Development Through Predictive Design By: John McDermott and Andy Lewis
Read More
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
Let's Talk
Your breakthrough therapy deserves momentum, and every day matters. Start a conversation with us today.